Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;33(4):610-618.
doi: 10.1038/s41433-018-0251-8. Epub 2018 Nov 20.

Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio

Collaborators, Affiliations

Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio

Sarah R Dawson et al. Eye (Lond). 2019 Apr.

Abstract

Purpose: To report on the composition and performance of the portfolio of Ophthalmology research studies in the United Kingdom's National Institute for Health Research (NIHR) Clinical Research Network (UK CRN).

Methods: Ophthalmology studies open to recruitment between 1 April 2010 and 31 March 2018 were classified by: sub-specialty, participant age, gender of Chief Investigator, involvement of genetic investigations, commercial/ non-commercial, interventional/observational design. Frequency distributions for each covariate and temporal variation in recruitment to time and target were analysed.

Results: Over 8 years, 137,377 participants were recruited (average of 15,457 participants/year; range: 5485-32,573) with growth by year in proportion of commercial studies and hospital participation in England (76% in 2017/18). Fourteen percent of studies had a genetic component and most studies (82%) included only adults. The majority of studies (41%) enrolled patients with retinal diseases, followed by glaucoma (17%), anterior segment and cataract (13%), and ocular inflammation (6%). Overall, 68% of non-commercial studies and 55% of commercial studies recruited within the anticipated time set by the study and also recruited to or exceeded the target number of participants.

Conclusions: High levels of clinical research activity, growth and improved performance have been observed in Ophthalmology in UK over the past 8 years. Some sub-specialties that carry substantial morbidity and a very high burden on NHS services are underrepresented and deserve more patient-centred research. Yet the NIHR and its CRN Ophthalmology National Specialty Group has enabled key steps in achieving the goal of embedding research into every day clinical care.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Members of the NIHR Ophthalmology Specialty Group:

Jane Ashworth, Clare Bailey, Susan Downes, Louise Downey, Sheena George, Irene Gottlob, Christopher Hammond, Simon Harding, Jonathan Jackson, Andrew Lotery, Martin McKibbin, Luke Membrey, Pádraig J. Mulholland, Nishal Patel, George M. Saleh, Roshini Sanders, Giuliana Silvestri, Velota Sung, Deepali Varma, Marcella Votruba, Emma Worrell, Brinda Shah, Ian Nickson, Michael Beresford, Vanessa Poustie, Emma Chambers, Sarah Cooper, Cathy Yelf, Geraldine Hoad, Michele Acton, Louise Gow, Matt Broom, Christine Dickinson, Padraig Mulholland, Manjo Doug, Robert Barry

Figures

Fig. 1
Fig. 1
Infrastructure facilities funded by the NIHR (reproduced with permission of NIHR)
Fig. 2
Fig. 2
Numbers of participants recruited into NIHR CRN Ophthalmology portfolio studies in the UK by year, with categorisation into commercial and non-commercial sponsorship, and by design (observational/interventional/both)
Fig. 3
Fig. 3
Numbers of participants (and number recruited per 100,000 population) recruited into UK CRN Ophthalmology portfolio studies in each of the 15 Local Clinical Research Networks and the devolved nations between 1 April 2010 and 31 March 2018
Fig. 4
Fig. 4
Numbers of UK CRN Ophthalmology portfolio studies classified by sub-specialty that were open between April 2010 and 31 March 2018
Fig. 5
Fig. 5
Sources of funding of UK CRN Ophthalmology portfolio studies by year between April 2010 and 31 March 2018. a Sources of funding of UK CRN Ophthalmology portfolio studies by year between April 2010 and 31 March 2018: non-commercial studies. b Sources of funding of UK CRN Ophthalmology portfolio studies by year between April 2010 and 31 March 2018: commercial studies

Comment in

  • The inverse-research law of eye health.
    Buchan JC, Dean WH, Ramke J, Burton MJ. Buchan JC, et al. Eye (Lond). 2019 Dec;33(12):1976-1977. doi: 10.1038/s41433-019-0528-6. Epub 2019 Jul 11. Eye (Lond). 2019. PMID: 31296951 Free PMC article. No abstract available.

References

    1. http://www.legislation.gov.uk/ukpga/2012/7/pdfs/ukpga_20120007_en.pdf. Accessed 1 July 2018.
    1. http://www.crncc.nihr.ac.uk/about_us/processes/portfolio. Accessed 1 July 2018.
    1. Bourne R, Gale R. The Ophthalmology Specialty Group and the National Institute for Health Research: the first 6 years. Eye. 2013;27:457–60. doi: 10.1038/eye.2013.22. - DOI - PMC - PubMed
    1. NIHR Clinical Research Network Open Data Platform. www.odp.nihr.ac.uk. Accessed 1 July 2018.
    1. Azuara-Blanco A, Burr J, Thomas R, Maclennan G, McPherson S. The accuracy of accredited glaucoma optometrists in the diagnosis and treatment recommendation for glaucoma. Br J Ophthalmol. 2017;91:1639–43. doi: 10.1136/bjo.2007.119628. - DOI - PMC - PubMed

MeSH terms